http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018185574-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0510dd419cf9cbc6bcce932921584bc2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16827
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-145
filingDate 2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48260e906da0bdc8ec2ed799a74a68ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11dee49f4b73089568ab5bb0f16170e3
publicationDate 2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018185574-A1
titleOfInvention Method and system for performing a continuous infusion process
abstract A method for performing a continuous infusion process using at least two infusion devices ( 1 A, 1 B) comprises the steps of: delivering a first fluid (M 1 ) from a first medication container ( 100 A) through a first delivery line ( 11 A) at a first flow rate (F 1 ) using a first infusion device ( 1 A) in a first phase; and delivering a second fluid (M 2 ) from a second medication container ( 100 B) through a second delivery line ( 11 B) at a second flow rate (F 2 ) using a second infusion device ( 1 B) in a second phase following the first phase. Herein, a relay device ( 2 ) connected to said first delivery line ( 11 A) and said second delivery line ( 11 B) is constituted to receive the first fluid (M 1 ) via the first delivery line ( 11 A) in the first phase and the second fluid (M 2 ) via the second delivery line ( 11 B) in the second phase, wherein the relay device ( 2 ) is further constituted to discharge the received first or second fluid (M 1 M 2 ) to an outlet delivery line ( 3 ) connected to the relay device ( 2 ) for administration to a patient (P), the outlet delivery line having a predefined delivery volume (DV). In addition it is provided that, subsequent to the delivery of the first fluid (M 1 ) using the first infusion device ( 1 A) in the first phase, the second infusion device ( 1 B) in an intermediate phase is operated for a predetermined delivery time to deliver the second fluid (M 2 ) at the first flow rate (F 1 ), the predetermined delivery time being determined taking the predefined delivery volume (DV) of the outlet delivery line ( 3 ) into account. In this way a method for performing a continuous infusion process using at least two infusion devices is provided, allowing for a continuous infusion at a desired, in particular constant dose rate in particular when switching from one infusion device to another.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114191647-A
priorityDate 2015-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420657405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667531

Total number of triples: 39.